ANALIZE MEDICALE DE LABORATOR
Aici gasiti analizele medicale grupate pe categorii precum si detalii generale si specifice pentru categoriile respective.
Selectati o categorie din lista de mai jos:
Solutie antistress!
Construieste poduri :)
Prinde pisica neagra :)
Ceregene Completes Enrollment Of Phase 2 Clinical Trial For Parkinson's Disease
Ceregene, Inc.
announced that the company has completed enrollment of its randomized,
controlled, double-blind, Phase 2 clinical trial evaluating CERE-120, a
gene therapy product in development for the treatment of Parkinson's
disease. The trial enrolled 58 patients with advanced Parkinson's disease
across nine medical centers in the United States. The company expects to
announce results from the trial in late 2008. CERE-120 is designed to
deliver the neurturin gene, a nervous system growth factor with the ability
to maintain the growth and normal function of dopamine-producing neurons
Ceregene completeaza de înscriere Din Faza 2 studiu clinic pentru boala Parkinson - Ceregene Completes Enrollment Of Phase 2 Clinical Trial For Parkinson's Disease - articole medicale engleza - startsanatate
